New Weight-Loss shot shows promise in early trial
NCT ID NCT06714955
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 20 times
Summary
This early-stage study tested a new injection called BGM0504 in 30 overweight or obese adults who do not have diabetes. The main goal was to check safety and side effects, and researchers also measured weight changes over 10 weeks. Participants received either the drug or a placebo, and the results will help decide if larger studies are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-DIABETIC OVERWEIGHT OR OBESE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pharmaron CPC, Inc
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.